Grant R. Zimmermann, PhD
Managing Director of Business Development, Blavatnik Biomedical Accelerator
Grant joined OTD in 2012. Prior to joining Harvard, Grant was Vice President of Strategic Alliances at Zalicus Inc. partnering an oncology-focused, combination-drug discovery platform with pharma and biotech. Previously, he was head of technology development and inflammation research at CombinatoRx, Inc. advancing multiple candidates through discovery and pre-clinical development, including a phase 2b candidate for rheumatoid arthritis. Grant holds a BS in biochemistry from the University of Illinois at Urbana-Champaign, and a PhD in chemistry from the University of Colorado at Boulder. He was an American Cancer Society postdoctoral fellow at Harvard Medical School.